Fast-tracked drugs are killing people

I bet you’ve seen the routine a thousand times. Whenever Big Pharma wants to rush through approval of one of its new drugs, it will taut it as the next ‘cure’ for whatever disease it is meant to treat.

It turns out that these fast-tracked drugs end up harming thousands of patients because they are rushed on to market before actually being proven to be safe. And with the medical authorities rubber-stamping new drugs at a record pace, there are more of these victims out there than ever before.

Two new studies, published in the British Medical Journal (BMJ), show that the American Food and Drug Administration (FDA) is not only rushing drugs to market based on shoddy evidence, but these fast-tracked drugs are causing more people to end up in the hospital or even dead.

You see, dangerous drugs that’s been rushed onto the market without adequate testing turns us into unsuspecting guinea pigs for the pharmaceutical industry.

And plenty of patients are paying the price. Here are just a few examples:

• Hundreds of patients died after the medical authorities pushed the dangerous blood-thinner Pradaxa onto the market after a short six-month review.

• The FDA had to revoke its approval of Avastin to treat breast cancer after research proved it didn’t work and could cause fatal bleeding.

• Since 1992, there’s been a 25 per cent increase in the number of drugs that are slapped with black box warnings or pulled from the shelves altogether over safety disasters. Most of these drugs should never have been approved in the first place.

The worst part is that researchers found that 90 per cent of these newly approved drugs don’t offer any clinical advantages over drugs that are already on the market. They’re both unnecessary and dangerous.

So how can you find out if a drug you’re taking may have been approved after a rushed, shoddy review? You can actually search the FDA’s database for detailed records on any approved med.

Just search, click on the drug and scroll down to “approvals history.” If you see a drug that was rushed through in six months or less — especially in the past 10 years — it should trigger a red flag and a conversation with your doctor.

Wishing you the best of health,

Dr. Glenn S. Rothfeld
Nutrition & Healing
Did you find this information useful?

If you enjoyed this content or found it useful and educational, please share this article with your friends and family.


2 new studies show the FDA is rushing more drugs to market based on shoddy evidence,

Do FDA’s Fast-Track Reviews Skimp on Important Data?,

Leave a comment

Be part of the conversation by becoming a Premium Member. Click here to learn more about membership.

Leave a Reply

Your email address will not be published. Required fields are marked *